Purchase Order 75N92022P00293
Award Date 8/26/22
Potential Completion Date 8/25/24
Potential Value $392K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Cambridge, MA 02142, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a firm fixed price purchase order contract to The Broad Institute, Inc., a non-profit biomedical and genomic research organization, to provide whole genome sequencing of sickle cell disease samples. The contract has a potential value of $187,500.00 and a completion date of July 6, 2023. The Broad Institute has extensive experience providing genomics and data services to the...
- This $202,500 firm-fixed price purchase order was awarded to The Broad Institute, Inc. by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH). The contract is for whole genome sequencing of sickle cell patient blood samples, with a completion date of September 21, 2025. The Broad Institute is a non-profit biomedical and genomic research organization that frequently partners with government agencies like NIH, CDC, and DoD to provide...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $145,590 purchase order to Clinical Research Sequencing Platform, LLC for clinical genome sequencing services. The prime contractor, Clinical Research Sequencing Platform, LLC, is a division of The Broad Institute, Inc. doing business as Broad Institute of MIT and Harvard. The firm fixed price contract runs from August 30, 2023 through December 31, 2023 to...
- The National Heart, Lung, and Blood Institute (NHLBI) awarded a $951.7K delivery order to The Broad Institute, Inc. for whole genome sequencing to identify somatic mutations in the Genotype-Tissue Expression (GTEx) project. This contract, which includes a no-cost extension with an ultimate completion date of July 25, 2022, operates under a firm fixed-price model with no set-aside designation. The work will be performed in Bethesda, Maryland, and represents a continuation of specialized genomic...
- The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $12,105.91 firm fixed price delivery order to Illumina, Inc. to provide DNA sequencing and genomics core requirements including Illumina library preparation kits. The place of performance is San Diego, California. The period of performance is from June 30, 2023 through September 29, 2023. The award supports the agency's biomedical research efforts by providing key...
- The National Heart, Lung and Blood Institute of the National Institutes of Health, Department of Health and Human Services, awarded a $35,041.80 firm fixed price delivery order to Illumina, Inc. to provide Illumina kits and reagents in support of next-generation sequencing activities on Illumina instruments for Institute-funded investigators. The sequencing core facility at the NHLBI requires the products from Illumina to carry out its mission of performing next-generation sequencing on Illumina...
- This firm fixed-price purchase order for $108,629.18 was awarded by the National Institute of Environmental Health Sciences, a civilian agency, to The Broad Institute, Inc. for whole exome sequencing services. The contract has no set-aside designation, reflecting The Broad Institute's competitive capabilities in advanced genomic research and data analysis services. The Broad Institute has performed similar work for other federal agencies like the Centers for Disease Control and Prevention,...
- The National Institutes of Health National Heart Lung and Blood Institute awarded a $484,000 purchase order contract to Psomagen Inc., a subsidiary of Macrogen, Inc., to provide Whole Genome Sequencing on DNA. The contract has a period of performance starting on May 17, 2022 through May 16, 2023 and utilizes a firm fixed price pricing structure. The place of performance will be Potomac, Maryland. Psomagen Inc. will perform whole genome sequencing services on DNA samples for the National Heart...
- The National Institutes of Health, National Heart Lung and Blood Institute awarded a firm fixed price purchase order valued at twelve thousand dollars to The Johns Hopkins University. Under this contract, the prime contractor will support the Fitzhugh Joseph Lab, Cardiovascular and Myeloproliferative Disorders Branch, Leukemia Section Myeloproliferative Neoplasms Program by conducting research to identify genetic risk factors for myeloid malignancy development after curative therapies for sickle...
- This is a $37,876,167 Firm Fixed Price definitive contract awarded by the National Heart Lung and Blood Institute (NHLBI) to The Broad Institute, Inc., a non-profit research organization. The contract supports the Trans-Omics for Precision Medicine (TOPMed) initiative through genomics data generation, analysis, and management services. This is an indefinite delivery contract with a 10-year, $500 million ceiling. The Broad Institute was also awarded a multiple-award Indefinite Delivery Indefinite...